Public page captured October 22, 2026. Promotional sheets and temporary interface overlays were dismissed or removed in the static reference. No personal or medical information was entered. Captured entry screens do not reproduce the complete consultation.

Visual reference: No-needle GLP-1 · pill between fingers. The main campaign sends price, medication-launch, creator and celebrity ads to one Serena-led entrance. A treatment-format question sits in the hero; choosing Learn about both reveals a weight-goal question without leaving the page. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
The headline names the objection it's answering. Plenty of people considering GLP-1s are put off by injections, and Ro's ad speaks to that in a few words, then shows the alternative as a tiny pill held between two fingers. The close crop makes the product the whole scene, so the size of the pill does the explaining. The small callouts around it (once daily, no insurance needed) add specifics without crowding the image.
The ad tells you what the pill isn't, but nothing tells the viewer why now or what it costs, and the callouts are too small to read at feed size. There's no proof element either, like a provider mention or a member voice. If you make one like this, keep the single-object image and the objection-led headline, then make one callout large enough to carry real weight (a price cue or how fast you hear back) so the viewer has a concrete reason to tap.
Showing the pill at real scale makes the no-injection promise visible before anyone reads a word.
It names the fear of needles directly, which is the reason this viewer hasn't started.
It explains the mechanism (a questionnaire, then an online prescription) and carries the required safety reference.
The ad sends people to Ro's quiz entry page, which is the strongest kind of destination on the landing-page ladder because it starts an assessment right away. The first question asks which option you're interested in, and "GLP-1 pill" is the first answer, so someone who tapped for the no-needle option can pick it in one click. Beyond that answer, the page shows Serena Williams as a Ro member and the Lose weight on Ro headline, with no mention of the pill format itself. A pill image next to that answer would make the match obvious. It's one of 71 ads in the Fluid library that land here.
Ro's main weight-loss landing page is a quiz entry: Serena Williams, labeled as a Ro member, stands beside a card asking which GLP-1 option you want. It's the destination for 71 Ro ads in the Fluid library, mostly price-led statics, Serena creator videos and pill-versus-pen product stills, nearly all ending on See if you qualify.
A pale yellow strip claims the lowest prices for GLP-1s are on Ro, the page's only answer to 'is this affordable?'
Lose weight on Ro names the category and the brand, so the visitor knows they're in the right place before reading anything else.
Serena holds a pen-style product with a Ro member label and a product thumbnail beside her, answering 'is this the thing from the ad?'
A white card asks which Ro option you're interested in (pill, shot, learn about both, or a provider recommendation), which starts the quiz and sorts visitors by how far along they are.
After Learn about both, the same card asks how much weight you're looking to lose in ranges plus Not sure yet, keeping the visitor on the page while the quiz continues.
Legal, terms, privacy and consumer health data privacy links sit beside a LegitScript Certified badge, answering 'is this a legitimate pharmacy?' for anyone who scrolls.
Read the full breakdown of this page
One of 100 Ro ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.